v1
Phase II trial of subcutaneous injections of human recombinant interleukin-2 for the treatment of mycosis fungoides and Sézary syndrome.
Identifier:nobleid.org/w1/20260515/9FFFE3BA
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/9FFFE3BA)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims